Automated Geriatric Co-Management Program in Older Patients With Solid Mass or Nodule Suspicious for Cancer


The purpose of this study is to find out if it is possible to use the automated geriatric co-management program to manage the participants care before, during and after surgery.

Full Title of Study: “Feasibility and Effectiveness of Automated Geriatric Co-Management Program on Improving the Perioperative Care of Older Patients With Solid Mass or Nodule Suspicious for Cancer”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Supportive Care
    • Masking: None (Open Label)
  • Study Primary Completion Date: March 2022


  • Other: in-person geriatric co-management
    • The geriatrics service sees these patients for at least 2 postoperative days, if deemed clinically necessary by the geriatrician. During the inpatient hospital course, the geriatrics service will ensure the execution of preoperative recommendations and will discuss with the surgical team, who will act as a primary team, any additional recommendation in order to improve postoperative care. “In-person” geriatric consults to be done via telemedicine due to the current pandemic and consideration for patient safety.
  • Other: automated geriatric co-management
    • Following completion of the eRFA, the summary of impairments as well as the recommendations generated by the study team (hard-copy or email) will be provided in real-time to the surgery team for their attention.

Arms, Groups and Cohorts

  • Active Comparator: In-person geriatric co-management group
    • “In-person” geriatric consults to be done via telemedicine due to the current pandemic and consideration for patient safety.
  • Experimental: Automated geriatric co-management program group

Clinical Trial Outcome Measures

Primary Measures

  • feasibility of automated geriatric co-management program
    • Time Frame: 2 years
    • percentage of recommendations that were followed by the surgery team

Participating in This Clinical Trial

Inclusion Criteria

  • Solid mass or nodule suspicious for cancer – Aged 65 or older – Being considered for surgical resection of the solid mass or nodule, with anticipated hospital length of stay of at least two days, – Completed the eRFA per routine care Exclusion Criteria:

  • Unable to read or comprehend English – Not having a completed electronic Rapid Fitness Assessment within 2 months of surgery**Note) To avoid excluding patients based this item, patients have to complete another eRFA within two months of surgery. – Being discharged in one day or earlier from the hospital.

Gender Eligibility: All

Minimum Age: 65 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Memorial Sloan Kettering Cancer Center
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Armin Shahrokni, MD, MPH, Principal Investigator, Memorial Sloan Kettering Cancer Center
  • Overall Contact(s)
    • Armin Shahrokni, MD, MPH, 646-888-3651,

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.